ERBB2 and breast cancer: Further analysis of the METABRIC breast cancer data set showed that AKAP8 expression positively correlates with overall survival (Fig. 1e), most significantly in Luminal A, Luminal B, and HER2 + subtypes (Supplementary Fig. 1c–g).